The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Protesting Spanish professor 'warned university' over Confucius Institutes — Radio Free Asia
Calligraphy, Painting Industry Thrives in E China's County
Smart China Expo 2023 Opens in China's Chongqing
Culture, Museum Craze Drives Consumption During China's Eight
Mariska Hargitay is mistaken for real
Asian Games Torch Relay Highlights Dreams in Shaoxing
China Takes 5th Consecutive Women's Team Title in Asiad Table Tennis
Relocated Villagers in Jinghai District of China's Tianjin Return Home As Flood Recedes
Rap artist GloRilla has been charged with drunken driving in Georgia
District attorney says Memphis police officer may have been killed by friendly fire
China Launches New Disaster Reduction Satellite